Monte Rosa Therapeutics, Inc. (GLUE) vs Lyell Immunopharma, Inc. (LYEL)
Detailed comparison between Monte Rosa Therapeutics, Inc., Lyell Immunopharma, Inc..Total Return (%)
Monte Rosa Therapeutics, Inc. (GLUE)Lyell Immunopharma, Inc. (LYEL)
Which stock do you think will perform better?
Monte Rosa Therapeutics, Inc.
GLUE
Lyell Immunopharma, Inc.
LYEL
| Metric | Monte Rosa Therapeutics, Inc. (GLUE) | Lyell Immunopharma, Inc. (LYEL) |
|---|---|---|
| Current Price | $7.41 | $16.24 |
| Change | 0.10 (1.37%) | 1.27 (8.48%) |
| Market Cap | $0.47B | $0.31B |
| Trailing P/E | 19.50 | 0.00 |
| Forward P/E | -4.94 | -19.33 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $12.40 | $30.00 |
| 52-Week Low | $3.50 | $7.65 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $0.38 | $-30.73 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| GLUE | 50.61% | 4.22% | 37.48% | -65.01% | -65.01% | -65.01% |
| LYEL | 42.33% | 25.89% | -33.98% | -95.19% | -95.19% | -95.19% |